Statistics
Publications
2
Citations
103
H-Index
2
Active since
2022
Affiliations
Aichi Cancer Center(Current)
Kentaro Hirade is an author at Aichi Cancer Center specializing in molecular oncology, oncology, and medicine.
Publications per year
2022–2023
2
2
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition
Jinyang Cai, Sheeba Jacob, Richard Kurupi et al. · Cell Reports · 2022 · 18 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–2 of 2